- Home
- TRVI vs CEPU Comparison
TRVI vs CEPU Comparison
Compare TRVI & CEPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRVI | CEPU |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TRVI | CEPU |
|---|---|---|
| Price | $12.50 | $11.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $28.18 | $23.81 |
| AVG Volume (30 Days) | ★ 2.5M | 253.4K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 7.42% |
| EPS Growth | ★ 31.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $61.36 |
| Revenue Next Year | N/A | $0.74 |
| P/E Ratio | ★ N/A | $12.24 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.82 | $11.66 |
| 52 Week High | $20.22 | $18.50 |
Technical Indicators
Market Signals| Indicator | TRVI | CEPU |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 35.58 |
| Support Level | $11.70 | N/A |
| Resistance Level | $13.55 | $15.38 |
| Average True Range (ATR) | 0.66 | 0.51 |
| MACD | 0.13 | -0.06 |
| Stochastic Oscillator | 44.81 | 20.71 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity. The company derives maximum revenue from Electric Power Generation from conventional sources segment.